Who owns Oncternal Therapeutics Inc?

Tip: Access positions for across all investors

Analyze quarterly positions in Oncternal Therapeutics with up to 7 years of data, all consolidated into one spreadsheet

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Top investors of Oncternal Therapeutics stock

Who bought or sold Oncternal Therapeutics Inc this quarter?

Fund or Company Name Shares Held Valued At Change in Shares As Of Actions
Vanguard Group 2.9M $1.5M 0% Dec 2023
 View chart
Millennium Management 2.1M $1.1M 25% Dec 2023
 View chart
BlackRock 786k $236k 0% Sep 2023
 View chart
Pasadena Private Wealth 500k $268k 79% Dec 2023
 View chart
Richmond Brothers 494k $265k 0% Dec 2023
 View chart
Geode Capital Management 476k $144k 15% Sep 2023
 View chart
Renaissance Technologies 313k $94k 9% Sep 2023
 View chart
LPL Financial 172k $51k 0% Sep 2023
 View chart
State Street Corporation 161k $49k 0% Sep 2023
 View chart
Ieq Capital 144k $77k 0% Dec 2023
 View chart
Morgan Stanley 98k $29k 0% Sep 2023
 View chart
Northern Trust 85k $25k 0% Sep 2023
 View chart
Two Sigma Advisers 84k $45k -15% Dec 2023
 View chart
Two Sigma Investments 75k $40k 0% Dec 2023
 View chart
Acadian Asset Management 73k $21k -33% Sep 2023
 View chart
Axxcess Wealth Management 70k $38k 0% Dec 2023
 View chart
Two Sigma Securities 59k $32k 177% Dec 2023
 View chart
Citadel Advisors 54k $29k 100% Dec 2023
 View chart
Envestnet Asset Management 54k $16k 0% Sep 2023
 View chart
Regents of the University of California 54k $29k 0% Dec 2023
 View chart
Balboa Wealth Partners 48k $26k 0% Dec 2023
 View chart
Creative Planning 39k $21k 0% Dec 2023
 View chart
Charles Schwab Investment Management 32k $17k 0% Dec 2023
 View chart
Beta Wealth 32k $17k 0% Dec 2023
 View chart
IPG Investment Advisors 23k $13k 100% Dec 2023
 View chart
Susquehanna International 22k $6.8k 20% Sep 2023
 View chart
Jpmorgan Chase & Co 20k $10k 0% Dec 2023
 View chart
Tower Research Capital 19k $5.8k -34% Sep 2023
 View chart
Advisor Group Holdings 8.9k $4.7k -29% Dec 2023
 View chart
Wells Fargo & Company 6.4k $3.4k 0% Dec 2023
 View chart
Bnp Paribas Arbitrage, Snc 3.6k $2.0k 0% Dec 2023
 View chart
UBS Group 2.0k $1.1k -85% Dec 2023
 View chart
Column Capital Advisors 1.5k $435.000000 0% Sep 2023
 View chart
Truvestments Capital 440.00 $132.000000 0% Sep 2023
 View chart
Steward Partners Investment Advisory 300.00 $161.010000 0% Dec 2023
 View chart
Bank of America Corporation 35.00 $19.001500 -99% Dec 2023
 View chart
Coppell Advisory Solutions 20.00 $11.000000 -66% Dec 2023
 View chart
Cetera Trust Company 7.00 $3.999800 100% Dec 2023
 View chart
Delta Asset Management 7.00 $3.999800 0% Dec 2023
 View chart
Qube Research & Technologies 1.00 $0 100% Sep 2023
 View chart

Who sold out of Oncternal Therapeutics?

Fund or Company Name Date Sold Shares Held Valued At
Quantum Private Wealth Sep 2023 459k $138k
Brighton Jones Sep 2023 339k $102k
CI Private Wealth Sep 2023 92k $28k
Mercer Global Advisors Sep 2023 54k $16k
Valeo Financial Advisors Sep 2023 35k $10k
Aureus Asset Management Sep 2023 30k $9.1k
Waypoint Capital Advisors Sep 2023 26k $7.9k
Mackenzie Financial Sep 2023 20k $6.0k
Bank of New York Mellon Sep 2023 18k $5.3k
Resources Investment Advisors Jun 2023 12k $4.0k
Jane Street Sep 2023 10k $3.1k
Baader Bank Sep 2023 10k $2.7k
North Star Investment Management Sep 2023 10k $3.0k
Royal Bank of Canada Sep 2023 10k $3.0k
Lindbrook Capital Sep 2023 300.00 $90.000000
Nemes Rush Group Sep 2023 71.00 $22.002900